Clinical Trial Update: Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial in completely resected Stage IB-IIIA non-small cell lung cancer comparing adjuvant Vinorelbine plus Cisplatin (NP) to NP plus Endostar; current st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Endostar (recombinant human endostatin)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Chinese Academy of Sciences | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: UNKNOWN